Your Notifications
All done, no notifications

What is Neuromyelitis Optica?

Neuromyelitis optica (NMO), now more commonly called neuromyelitis optica spectrum disorder (NMOSD), is a rare autoimmune disorder that affects the central nervous system, particularly the optic nerves and spinal cord. NMOSD can cause episodes of optic neuritis, transverse myelitis and other neurological syndromes, potentially resulting in vision loss, muscle weakness, sensory disturbances or bladder and bowel problems. Early diagnosis is important because NMOSD requires a different treatment approach from multiple sclerosis and other demyelinating disorders.

What is the Importance of Timely Treatment?

NMOSD attacks can cause substantial neurological damage and may result in persistent disability if not treated promptly. Early recognition of optic neuritis, transverse myelitis or other characteristic symptoms allows doctors to begin acute treatment and reduce inflammation as quickly as possible. Long-term preventive therapy may also be required because recurrent attacks can accumulate neurological disability. Accurate diagnosis is particularly important because some treatments used for multiple sclerosis may be inappropriate or potentially harmful in NMOSD.

What are the Common Symptoms of Neuromyelitis Optica?

  • Eye pain, particularly with eye movement
  • Blurred or reduced vision, often affecting one or both eyes
  • Loss of colour vision
  • Partial or severe vision loss
  • Limb weakness or paralysis
  • Numbness, tingling or altered sensation
  • Painful muscle spasms
  • Difficulty walking or maintaining balance
  • Loss of bladder or bowel control
  • Nausea and persistent or unexplained vomiting
  • Persistent or severe hiccups
  • Facial weakness or other brainstem symptoms
  • Symptoms related to inflammation in the brain or other central nervous system regions

Causes and Risk Factors of Neuromyelitis Optica

Causes

  • NMOSD is an autoimmune disease in which the immune system mistakenly attacks the central nervous system. In AQP4-IgG-positive NMOSD, antibodies damage cells called astrocytes, causing inflammation and injury to nearby nerve tissues.
  • Some patients have NMOSD symptoms but test negative for AQP4-IgG antibodies. Doctors assess their symptoms, MRI scans, and other test results to confirm the diagnosis.
  • MOG antibody-associated disease (MOGAD) can cause similar symptoms, such as optic neuritis and spinal cord inflammation. However, MOGAD is distinct from NMOSD.

Risk Factors

  • Female sex, particularly in AQP4-IgG-positive disease
  • Presence of AQP4-IgG antibodies
  • Personal or family history of autoimmune disorders
  • Coexisting autoimmune conditions
  • Previous NMOSD attack
  • Certain genetic and immune-system factors
  • MOG-IgG positivity in patients with a different demyelinating disease phenotype

Latest Research and Technologies in the Treatment of Neuromyelitis Optica in Thailand

  • Research into NMOSD increasingly focuses on improving antibody-based diagnosis, promptly treating acute attacks, and preventing future relapses through targeted immunotherapy. When available, serum AQP4-IgG testing using cell-based assays is preferred because it improves diagnostic accuracy. MOG-IgG testing can help distinguish MOGAD from NMOSD in appropriate patients.

Treatment options for Neuromyelitis Optica

Plasma Exchange : Plasma exchange may be used when a severe attack responds inadequately to corticosteroids or when rapid removal of pathogenic antibodies is required. Selected specialist centres may offer immunoadsorption.


Cost Start From 700Explore Options

Targeted Therapies : For AQP4-IgG-positive NMOSD, targeted therapies include complement inhibition and B-cell-directed therapy with receptor blockade. Regulatory indications and availability vary between countries.

  • Clinical assessment:
    • Neurological Evaluation: A detailed neurological examination assesses vision, eye movements, muscle strength, reflexes, sensation, coordination, gait and bladder or bowel function. The history focuses on the timing and pattern of attacks, previous neurological episodes, recovery between attacks and associated symptoms such as persistent vomiting or hiccups.
    • AQP4-IgG Antibody Testing: Serum AQP4-IgG testing is an important component of NMOSD evaluation. Cell-based assays are preferred when available because they offer improved sensitivity and specificity compared with some older tests.
    • MOG-IgG Testing: Consider MOG-IgG testing, particularly in AQP4-IgG-negative patients or when clinical and imaging features suggest MOG-associated disease.
    • Cerebrospinal Fluid Assessment: Lumbar puncture may be performed in selected patients to analyse cerebrospinal fluid and help distinguish NMOSD from infections, multiple sclerosis and other inflammatory or neurological disorders.
    • Visual and Neurophysiological Assessment: Visual acuity, colour vision, visual fields, optical coherence tomography and visual evoked potentials may help evaluate optic nerve involvement and establish a baseline for monitoring visual function.
  • Imaging Tests:
    • MRI of the Brain: Helps identify lesions affecting the brainstem, area postrema, diencephalon and other characteristic regions and helps exclude alternative diagnoses.
    • MRI of the Spinal Cord: Particularly important for evaluating transverse myelitis. Longitudinally extensive spinal cord lesions involving multiple vertebral segments are characteristic of NMOSD, although shorter lesions can also occur.
    • MRI of the Optic Nerves: Helps identify optic neuritis, including lesions involving long segments of the optic nerve or optic chiasm.
    • Contrast-Enhanced MRI: May demonstrate active inflammation and help assess disease activity.
    • Optical Coherence Tomography: Provides detailed assessment of retinal nerve-fibre and ganglion-cell layers and may help monitor structural effects of optic neuritis.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Neuromyelitis Optica patients in Thailand. These services include:

  • Physiotherapy and Strength Training: Physiotherapy can help maintain muscle strength, flexibility, balance, and mobility after spinal cord injury or other neurological conditions.
  • Gait and Mobility Rehabilitation: Patients with leg weakness, balance problems or spasticity may receive gait training, transfer training and appropriate assistive-device support.
  • Vision Rehabilitation: Patients with persistent visual impairment may benefit from low-vision assessment, visual aids, environmental adaptations and training to improve independence.
  • Bladder, Bowel and Functional Rehabilitation: Occupational and rehabilitation specialists can help patients manage bladder or bowel dysfunction, transfers, self-care and activities of daily living.
  • High-dose intravenous corticosteroids are commonly used to control acute inflammation. Patients with confirmed NMOSD, particularly AQP4-IgG-positive disease, may require ongoing immunotherapy to reduce the risk of future attacks. Options include targeted biological medicines and conventional immunosuppressive therapies.Additional medicines may be prescribed for neuropathic pain, muscle spasms, spasticity, bladder symptoms or other complications.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Neuromyelitis Optica in Thailand

MALI Interdisciplinary Hospital: Top Doctors, and Reviews
MALI Interdisciplinary Hospital

Bangkok, Thailand

MALI Interdisciplinary Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • Operating Room
  • X-Ray Department
  • Laboratory
  • Inpatient Department
  • Emergency Department
Message Us
Bangpakok 9 International Hospital: Top Doctors, and Reviews
Bangpakok 9 International Hospital

Bangkok, Thailand

Bangpakok 9 International Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • It would be prudent to summarise the Medical Services provided at the Bangpakok 9 International Hospital (BPK 9), Bangkok, Thailand:
  • Cosmetic Dentistry
  • Dental Implants
  • Electrocardiogram (EKG or ECG)
  • Exercise Stress Test
  • Health Screening
  • Laser Vagina Firming
  • Pediatric Physical Therapy
  • Perfect Slim by Vela II
  • Physical Therapy for Musculoskeletal
  • Prosthodontics
  • The Medical Services are also inclusive of the International Patient Services such as the ones listed here:
  • Thai, English, French, Arabic, Chinese, Myanmar, Cambodia, Bangladeshi, Bahasa and Tagalog are the languages in which there are Translation services available for International Patients.
  • Visa extension related assistance
  • International health insurance related assistance
  • Embassy and international organizations related assistance
  • A variety of meals of choice for International Patients
  • Email consultation services
  • Transfer to either airport and/or hotels
  • Prayer room
  • Four different types of rooms are available such as Deluxe room, two kinds of suites, and a VIP suite.
  • Hospital facilities like The Coffee shop, Food Hall, Cafe and Medical Spa.
  • Complete health and safety protocols are maintained in the various Medical Centers some of whom are as follows:
  • Aesthetic Center
  • 24 Hour Emergency Center
  • Allergy Center
  • Breast Center
  • bSmart Center
  • Checkup Center
  • Dental Center,
  • Happy Long Life Center
  • Medical Fitness Center
  • Psychiatric Center
  • Rehabilitation Center
  • Sleep Disorders Center
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Thailand for Neuromyelitis Optica Treatment?

  • Multidisciplinary Neurological Care: Patients can access neurologists, neuroimmunology specialists, neuro-ophthalmologists, rehabilitation physicians, and other specialists as needed.
  • Advanced Diagnostic Facilities: Specialised centres may provide AQP4-IgG and MOG-IgG testing, MRI of the brain, optic nerves and spinal cord, CSF analysis and neurophysiological assessments.
  • Acute Attack Management: Confirm that the hospital can promptly provide high-dose intravenous corticosteroids, plasma exchange and appropriate monitoring for severe attacks.
  • Long-Term Immunotherapy: Ask which relapse-prevention treatments are available, approved for the patient's specific diagnosis and suitable for their antibody status and medical history.
  • Rehabilitation and Follow-Up: Check access to physiotherapy, occupational therapy, vision rehabilitation, bladder-management support and long-term neurological monitoring.

Frequently Asked Questions

Recovery varies according to the severity and location of the attack, how quickly treatment is started and the degree of neurological injury. Some patients improve substantially over weeks or months, while severe optic neuritis or spinal cord attacks can leave persistent visual, motor or sensory deficits. Rehabilitation may continue long after the acute attack.

Yes. Many patients with NMOSD can walk, particularly when neurological involvement is mild or treatment has controlled the attack. However, spinal cord inflammation can cause significant leg weakness, balance problems or paralysis during an acute attack. Physiotherapy, gait training and assistive devices may help restore or maintain mobility.

Major Thai neurological centres may provide brain, spinal cord, and optic nerve MRI; AQP4-IgG and MOG-IgG testing; cerebrospinal fluid analysis; visual assessments; electrophysiological testing; IV corticosteroid therapy; and plasma exchange. Selected centres may also offer targeted biological therapies, subject to regulatory approval and availability.

Many major Thai hospitals have international-patient departments that can assist with medical records, specialist consultations, treatment coordination, travel arrangements, accommodation and follow-up care.

Look for a neurological centre experienced in autoimmune and demyelinating disorders, with access to AQP4-IgG and MOG-IgG testing, advanced MRI, acute immunotherapy, and plasma exchange. For patients with significant disability, access to multidisciplinary neurological rehabilitation and neuro-ophthalmology services can also be important.

There is no single success rate for NMOSD treatment. Outcomes depend on antibody status, attack severity and location, treatment speed, number of previous relapses, degree of neurological damage, and response to preventive therapy. Treatment aims to control acute inflammation and reduce future attacks because recurrent attacks can cause cumulative disability.

Neurologists and specialists in neuroimmunology at major Thai neurological centres manage NMOSD and related autoimmune demyelinating disorders. Patients with complex disease may benefit from centres with access to advanced antibody testing, neuroimaging, plasma exchange, targeted immunotherapy and multidisciplinary rehabilitation.

Treatment risks depend on the therapy used. High-dose corticosteroids can cause metabolic and gastrointestinal effects and other short-term complications. Plasma exchange can cause blood-pressure changes, bleeding or vascular-access complications. Long-term immunosuppressive and biological therapies can increase infection risk and may require monitoring of blood counts, liver function, immunoglobulin levels or other laboratory parameters. Targeted therapies also have medicine-specific risks that you should discuss with the treating neurologist.

NMOSD is not an injury. New vision loss, painful eye movements with reduced vision, rapidly developing limb weakness, difficulty walking, new sensory loss, or bladder or bowel dysfunction requires urgent medical assessment. Persistent unexplained vomiting or hiccups may also indicate involvement of the area postrema and should be evaluated promptly, particularly in someone with known NMOSD.

Yes. NMOSD attacks can damage the optic nerves, spinal cord and other parts of the central nervous system. Possible lasting effects include visual impairment, limb weakness, spasticity, sensory changes, pain and bladder or bowel dysfunction. Not every attack causes permanent disability, but prompt treatment and effective relapse prevention are important because repeated attacks can accumulate neurological injury.

Yes. Vision loss, mobility difficulties, pain, fatigue, bladder or bowel problems and uncertainty about future attacks can affect work, education, relationships and independence. Appropriate relapse-prevention treatment, rehabilitation, assistive devices and psychological support can help patients manage daily activities and improve quality of life.

An untreated or inadequately treated acute attack can cause permanent damage to the optic nerves, spinal cord or other central nervous system structures. Consequences may include severe vision loss, paralysis, sensory impairment and bladder or bowel dysfunction. Prompt treatment of acute attacks and appropriate long-term relapse prevention are essential parts of care.

There is no established way to prevent NMOSD from developing in someone who has not previously had the disease. For people diagnosed with NMOSD, the key preventive strategy is reducing the risk of future attacks through appropriate immunotherapy and regular specialist follow-up. Vaccination and infection-prevention plans should be discussed with the treating clinician, particularly before or during immunosuppressive treatment.

NMOSD can affect people of different ages and backgrounds, but AQP4-IgG-positive disease is more common in women. Some patients also have other autoimmune conditions. A family history is not necessary for NMOSD to develop. Diagnosis requires assessment of symptoms, MRI findings, antibody results and alternative conditions, including multiple sclerosis and MOGAD.

Author

Pragun Gupta
Pragun Gupta

Doctor of Pharmacy

1 Year of Experience

Pragun Gupta is a Doctor of Pharmacy (Pharm. D.) professional from Teerthanker Mahaveer University with hands-on experience in clinical pharmacology, clinical research, and evidence-based medical writing. Through her clinical and research exposure, she has developed a strong interest in pharmacoeconomics, pharmacology, therapeutics, and pharmacovigilance.

As a medical writer, she works on medical and scientific research articles, patient education materials, and healthcare-focused content. Her clinical research and evidence-based writing experience enables her to translate complex medical information into clear, accurate, patient-friendly content while maintaining scientific credibility and medical accuracy. Her primary aim is to make healthcare information accessible and easy for patients and general readers to understand.

View More

Reviewer

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Hematologist

9 Years of Experience

Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More

Last Reviewed - January 2026